At Novartis, we are driven by our purpose. We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
70 billion doses of medicine touched the lives of 799 million patients in approximately 155 countries last year.
Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science. As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society.
The Innovative Medicines Division has two business units:
Novartis Pharmaceuticals focuses on patented treatments in multiple disease areas to enhance health outcomes for patients and offer solutions to healthcare providers.
Novartis Oncology focuses on patented treatments for a variety of cancers and rare diseases.
Sandoz offers patients and healthcare professionals high-quality, affordable generics and biosimilars.
Functional organizations with a global reach:
Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. NIBR focuses on discovering new drugs that can change the practice of medicine.
Global Drug Development (GDD) organization oversees the development of new medicines discovered by our researchers and partners.
Novartis Technical Operations (NTO) is responsible for making our innovative medicines, devices and Sandoz products and delivering them to our customers across the world.
Novartis Business Services (NBS) consolidates support services across our organization, helping drive efficiency, simplification, standardization and quality.
Corporate Functions support the enterprise in specific areas of expertise, including finance, human resources, legal and communications.
In this world of digital and technological transformation, we must also ask ourselves this: how can we continue to improve and extend even more people’s lives?
We believe the answers are found when curious, courageous and collaborative people like you are brought together in an inspiring environment. Where you’re given the opportunity to explore the power and potential of data and digital. Where you’re empowered to risk failure by taking smart risks. Where you’re encouraged to share new ideas that can open up new ways of making things happen. And where you’re surrounded by teams who are equally determined to transform lives by tackling the world’s toughest medical challenges.
While our diverse workforce brings different people and perspectives together, inclusion is making the mix work. It is about creating an atmosphere and an environment where each of us feels valued, respected and heard.
Novartis AG, incorporated on February 29, 1996, is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products. The Company’s healthcare solutions portfolio includes medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Its businesses are divided on a worldwide basis into the four operating divisions: Pharmaceuticals, which comprises brand-name patented pharmaceuticals; Vaccines and Diagnostics, which focuses on human vaccines and blood-testing diagnostics; Sandoz, which consists generic pharmaceuticals, and Consumer Health, which includes over-the-counter medicines, animal health medicines, and contact lenses and lens-care products. It operates in approximately 140 countries.
(Source: 20-F) – menos